Skip to main content Skip to section navigation Skip to footer

Inhibikase Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Science Advisors
  • Technology
    • Overview
    • RAMP™ Drug Innovation Engine
  • Pipeline
    • Overview
    • IkT-148009 for Parkinson’s Disease and GI complications
    • IkT-001Pro for CML
    • IkT-01427 for PML
    • Collaborative Programs
    • Partnering with Inhibikase
  • Scientific Publications
  • Clinical Trials
  • News
    • Press Releases
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • Careers

Press Releases

News

News

  • Press Releases
May 16, 2022 5:00pm EDT

Inhibikase Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity

May 10, 2022 8:05am EDT

Inhibikase Therapeutics to Participate at the H.C. Wainwright Global Investment Conference

May 09, 2022 4:05pm EDT

Inhibikase Therapeutics to Report First Quarter 2022 Financial Results on May 16, 2022

Apr 21, 2022 4:05pm EDT

Inhibikase Therapeutics to Participate at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference

Apr 06, 2022 8:00am EDT

Inhibikase Therapeutics to Host Virtual KOL Investor Event on April 20, 2022

Mar 31, 2022 5:00pm EDT

Inhibikase Therapeutics Reports Full Year 2021 Financial Results and Highlights Recent Period Activity

Mar 28, 2022 8:00am EDT

Inhibikase Therapeutics to Participate in the Next Generation Kinase Inhibitors Summit

Mar 25, 2022 8:00am EDT

Inhibikase Therapeutics to Report Full Year 2021 Financial Results on March 31, 2022

Mar 23, 2022 8:00am EDT

Inhibikase Therapeutics to Participate in the Maxim Group 2022 Virtual Growth Conference

Mar 08, 2022 8:00am EST

Inhibikase Therapeutics to Present Phase 1/1b Clinical Data at the Upcoming AD/PD™ Alzheimer's & Parkinson's Diseases Conference

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • arrow_forward
rss_feed News RSS
  • Visit us on Facebook
  • Visit us on Twitter
  • Visit us on Linkedin
  • Visit us on Youtube
©2023 Inhibikase Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap